The proposed bill aims to regulate the potency of cannabis products sold at medical cannabis dispensaries in South Dakota. It introduces a new section to chapter 34-20G, establishing specific limits on the tetrahydrocannabinol (THC) content for various cannabis products. According to the bill, dispensaries will be prohibited from acquiring or selling cannabis flower that exceeds 30% THC, liquid concentrate products over 60% THC, edible products with more than 5 milligrams of THC per serving or 100 milligrams per container, and cannabis oil that exceeds 5% THC.

These regulations are intended to ensure the safety and responsible use of medical cannabis by limiting the potency of products available to patients. By setting these thresholds, the bill seeks to address concerns regarding the potential for misuse and adverse effects associated with high-potency cannabis products.